CrystalGenomics, Inc. (083790.KQ)

KRW 2545.0

(0.99%)

Revenue Summary of CrystalGenomics, Inc.

CrystalGenomics, Inc.'s latest annual revenue in 2023 was 4.87 Billion KRW , up 12.9% from previous year.
CrystalGenomics, Inc.'s latest quarterly revenue in 2024 Q2 was 2.18 Billion KRW , up 207.43% from previous quarter.
CrystalGenomics, Inc. reported a annual revenue of 4.32 Billion KRW in annual revenue 2022, down -89.8% from previous year.
CrystalGenomics, Inc. reported a annual revenue of 42.37 Billion KRW in annual revenue 2021, up 40.21% from previous year.
CrystalGenomics, Inc. reported a quarterly revenue of 709.1 Million KRW for 2024 Q1, up 105.22% from previous quarter.
CrystalGenomics, Inc. reported a quarterly revenue of 4.87 Billion USD for 2023 FY, up 12.9% from previous quarter.

Annual Revenue Chart of CrystalGenomics, Inc. (2023 - 2013)

Historical Annual Revenue of CrystalGenomics, Inc. (2023 - 2013)

Year	Revenue	Revenue Growth
2023	4.87 Billion KRW	12.9%
2022	4.32 Billion KRW	-89.8%
2021	42.37 Billion KRW	40.21%
2020	30.22 Billion KRW	154.76%
2019	14 Billion KRW	5.73%
2018	13.88 Billion KRW	3.05%
2017	12.17 Billion KRW	2.38%
2016	14.52 Billion KRW	4.4%
2015	6.13 Billion KRW	7.51%
2014	4.53 Billion KRW	3.58%
2013	4.79 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q2	2.18 Billion KRW	207.43%
2024 Q1	709.1 Million KRW	105.22%
2023 FY	4.87 Billion USD	12.9%
2023 Q1	8.82 Billion USD	139.05%
2023 Q3	6.23 Billion USD	-7.51%
2023 Q2	6.74 Billion KRW	-23.59%
2023 Q4	-13.57 Billion USD	-317.77%
2022 FY	4.32 Billion USD	-89.8%
2022 Q3	5.34 Billion USD	0.0%
2022 Q1	3.86 Billion USD	14.7%
2022 Q4	3.69 Billion USD	-30.99%
2021 Q4	3.36 Billion USD	-31.42%
2021 FY	42.37 Billion USD	40.21%
2021 Q1	3.65 Billion USD	15.75%
2021 Q3	4.91 Billion USD	0.0%
2020 Q1	2.77 Billion USD	-0.49%
2020 Q3	4.54 Billion USD	0.0%
2020 Q4	3.15 Billion USD	-30.61%
2020 FY	30.22 Billion USD	154.76%
2019 Q1	2.78 Billion USD	13.57%
2019 Q3	3.98 Billion USD	0.0%
2019 FY	11.86 Billion USD	5.73%
2019 Q4	2.79 Billion USD	-29.97%
2018 Q4	2.45 Billion USD	-31.14%
2018 FY	11.22 Billion USD	3.05%
2018 Q3	3.55 Billion USD	0.0%
2018 Q1	2.66 Billion USD	10.24%
2017 FY	10.88 Billion USD	2.38%
2017 Q1	2.61 Billion USD	14.41%
2017 Q3	3.51 Billion USD	0.0%
2017 Q4	2.41 Billion USD	-31.3%
2016 FY	10.63 Billion USD	4.4%
2016 Q4	2.28 Billion USD	-32.65%
2016 Q3	3.39 Billion USD	0.0%
2016 Q1	2.59 Billion USD	14.91%
2015 Q3	3.29 Billion USD	0.0%
2015 Q1	2.49 Billion USD	10.3%
2015 FY	10.18 Billion USD	7.51%
2015 Q4	2.25 Billion USD	-31.4%
2014 FY	9.47 Billion USD	3.58%
2014 Q1	2.34 Billion USD	11.84%
2014 Q3	3.04 Billion USD	0.0%
2014 Q4	2.26 Billion USD	-25.89%
2013 Q1	2.2 Billion USD	18.9%
2013 Q4	2.09 Billion USD	-32.37%
2013 FY	9.14 Billion USD	0.0%
2013 Q3	3.09 Billion USD	0.0%
2012 Q4	1.85 Billion USD	0.0%

Peer Revenue Comparison of CrystalGenomics, Inc.

Name	Revenue	Revenue Difference
HLB Co., Ltd.	42.9 Billion KRW	88.628%
iNtRON Biotechnology, Inc.	9.58 Billion KRW	49.103%
BINEX Co., Ltd.	154.82 Billion KRW	96.849%
Bioneer Corporation	263.23 Billion KRW	98.147%
Anterogen.Co.,Ltd.	6.5 Billion KRW	24.947%
MEDIPOST Co., Ltd.	68.64 Billion KRW	92.893%
Helixmith Co., Ltd	4.2 Billion KRW	-16.114%
Chabiotech Co.,Ltd.	953.95 Billion KRW	99.489%
Medy-Tox Inc.	221.12 Billion KRW	97.794%
Peptron, Inc.	3.34 Billion KRW	-45.985%
Amicogen, Inc.	159.9 Billion KRW	96.949%
Genexine, Inc.	4.42 Billion KRW	-10.212%
HLB Therapeutics Co.,Ltd.	53.74 Billion KRW	90.923%
LegoChem Biosciences, Inc.	34.14 Billion KRW	85.712%
ALTEOGEN Inc.	96.52 Billion KRW	94.946%
PharmaResearch Co., Ltd.	261.01 Billion KRW	98.131%
SillaJen, Inc.	3.93 Billion KRW	-23.838%
JETEMA, Co., Ltd.	58.71 Billion KRW	91.691%
OliX Pharmaceuticals,Inc	17.06 Billion KRW	71.41%
Genomictree Inc.	3.41 Billion KRW	-42.734%
MedPacto, Inc.	- KRW	-Infinity%
D&D Pharmatech	18.67 Billion KRW	73.879%
EASY BIO,Inc.	165.38 Billion KRW	97.05%
GI Innovation, Inc.	5.31 Billion KRW	8.276%